Your Top 100 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

1646MO Phase II ATLEP trial: Final results for lenvatinib/pembrolizumab in metastasized anaplastic and poorly differentiated thyroid carcinoma

C. Dierks, Juri Ruf, Jochen Seufert, M. Kreissl, C. Klein, Christine Spitzweg and 5 more

Rank
68 of 3,616
Percentile
top 1.9%
Where
Annals of Oncology, 2022
Citations
62

From the 2022 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.